Blood-Brain Barrier (BBB) Disruption Using a Diagnostic Ultrasound Scanner and Definity® in Mice
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The objective of this work was to determine whether diagnostic ultrasound and contrast agent could be used to transcranially and nondestructively disrupt the blood-brain barrier (BBB) in mice under ultrasound image guidance, and to quantify that disruption using MRI and MR contrast agent. Each mouse was placed under isoflurane anesthesia and the hair on top of its skull was removed before treatment. A diagnostic ultrasound transducer was placed in a water bag coupled with gel to the mouse skull. Definity (US contrast) and Magnevist (MR contrast) were injected concurrent with the start of a custom ultrasound transmission sequence. The transducer was translated along the rostral-caudal axis to insonify three spatial locations (2 mm apart) along one half of the brain for each sequence. T1-weighted MR images were used to quantify the volume of tissue over which the BBB disruption allowed Magnevist to enter the brain, based upon increases in MR contrast-to-noise ratio (CNR) as compared to the noninsonified portions of the brain. Ultrasonic frequency, pressure, and pulse duration, as well as Definity dose and injection time were varied. Preliminary results suggest that a threshold exists for BBB opening dependent upon both pressure and pulse duration (consistent with reports in the literature performed at lower frequencies). A range of typical diagnostic frequencies (e.g., 5.0-8.0 MHz) generated BBB disruption. Comparable BBB opening was noted with varied delays between Definity injection and insonification (0-2 min) for a range of Definity concentrations (400-2400 μL/kg). The low-pressure, custom sequences (MI≤0.65) had minimal blood cell extravasation as determined by histological evaluation. This study has shown the ability of a diagnostic ultrasound system, in conjunction with Definity, to open the BBB transcranially in a mouse model for molecules approximately 0.5 kDa in size. Opening was achieved at higher frequencies than previously reported and was localized under ultrasound image guidance. A typical, ultrasound imaging mode (PW Doppler) with specific settings (transmit frequency=5.7 MHz, gate size=15 mm, pulse repetition frequency=100 Hz, system power=15%) successfully opened the BBB, which facilitates implementation using the majority of commercially available clinical diagnostic scanners. Localized opening of the BBB may have potential clinical utility for the delivery of diagnostic or therapeutic agents to the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hynynen, K., McDannold, N., Sheikov, N. A., Jolesz, F. A., & Vykhodtseva, N. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.046 · Cited by 679
Hay, P. J., Mond, J., Buttner, P., & Darby, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001541 · Cited by 335
The Area Postrema: A Brain Monitor and Integrator of Systemic Autonomic State
Price, C. J., Hoyda, T. D., & Ferguson, A. V. (2008) · The Neuroscientist · doi:10.1177/1073858407311100 · Cited by 257 · cited 1×
“…and pericytes (Ballabh et al, 2004); however, in some brain structures (e.g., circumventricular organs, such as the subfornical organ, area postrema, organum vasculosum of the lamina terminalis), the BBB is incomplete or leaky (McKinley et al, 1998; Price et al, 2008; Hashimoto et al, 1994).”
BackgroundHynynen, K., McDannold, N., Martin, H., Jolesz, F. A., & Vykhodtseva, N. (2003) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(02)00741-x · Cited by 144
Cho, C.-W., Liu, Y., Cobb, W. N., Henthorn, T. K., Lillehei, K., Christians, U., & Ng, K.-Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1019837923906 · Cited by 69 · cited 2×
“In cell monolayers, mild hyperthermia (41°C) using ultrasound (20 min, 0.4 W/cm2) has been shown to reversibly enhance passive diffusion of hydrophobic drugs and allow them to bypass efflux transporters (Cho et al, 2002).”
BackgroundMethodInfluential
Cited by
Aryal, M., Arvanitis, C. D., Alexander, P. M., & McDannold, N. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.008 · Cited by 443
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
Satapathy, M. K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., & Yang, C.-H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081183 · Cited by 318
“Moreover, there are several approaches developed to increase the permeability of the BBB such as injection of hyperosmolar mannitol [32] causing reversible disruption, or by providing ultrasound as physical stimulus [33,34].”
Fan, C.-H., Liu, H.-L., Ting, C.-Y., Lee, Y.-H., Huang, C.-Y., Ma, Y.-J., Wei, K.-C., Yen, T.-C., & Yeh, C.-K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096327 · Cited by 84
Microbubble-Assisted Ultrasound for Drug Delivery in the Brain and Central Nervous System
Burgess, A., & Hynynen, K. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-22536-4_16 · Cited by 62
Metadata
- Authors
- Bing, K. F., Howles, G. P., Qi, Y., Palmeri, M. L., & Nightingale, K. R.
- Venue
- Ultrasound in Medicine & Biology
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 35
- Issue
- 8
- Pages
- 1298-1308
- ISSN
- 0301-5629 (ISSN-L)
- OpenAlex
- W2015639902
- Cited by
- 90
- References
- 5
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood-Brain Barrier (BBB) Disruption Using a Diagnostic Ultrasound Scanner and Definity® in Mice. https://app.cochat.ai/papers/10.1016/j.ultrasmedbio.2009.03.012
- The paper
- Bing, K. F., Howles, G. P., Qi, Y., Palmeri, M. L., & Nightingale, K. R. (2009). Blood-Brain Barrier (BBB) Disruption Using a Diagnostic Ultrasound Scanner and Definity® in Mice. Ultrasound in Medicine & Biology. https://doi.org/10.1016/j.ultrasmedbio.2009.03.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.